Log In
Print this Print this

Insugen N

  Manage Alerts
Collapse Summary General Information
Company Biocon Ltd.
DescriptionLong-acting biosimilar recombinant human insulin
Molecular Target
Mechanism of ActionBiosimilar
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsTreat Type I diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today